[1] Stanton RC.Clinical challenges in diagnosis and management of diabetic kidney disease[J]. Am J Kidney Dis,2014,63(2 Suppl 2):S3-S21.
[2] Ricardo AC, Madero M, Yang W, et al.Adherence to a healthy lifestyle and all-cause mortality in CKD[J]. Clin J Am Soc Nephrol,2013,8(4):602-609.
[3] National Kidney Foundation.KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update[J]. Am J Kidney Dis,2012,60(5):850-886.
[4] Fontana L, Weiss EP, Villareal DT, et al.Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans[J]. Aging Cell,2008,7(5):681-687.
[5] Tönshoff B, Kaskel FJ, Moore LC.Effects of insulin-like growth factor I on the renal juxtamedullary microvasculature[J]. Am J Physiol,1998,274(1 Pt 2):F120-F128.
[6] Tsukahara H, Gordienko DV, Tonshoff B, et al.Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells[J]. Kidney Int,1994,45(2):598-604.
[7] Peters H, Border WA, Noble NA.Angiotensin Ⅱ bloc-kade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis[J]. Kidney Int,2000,57(4):1493-1501.
[8] Fukui M, Nakamura T, Ebihara I, et al.Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-beta in experimental glomerular sclerosis[J]. J Lab Clin Med,1993, 121(2):224-234.
[9] Zeller K, Whittaker E, Sullivan L, et al.Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus[J]. N Engl J Med,1991,324(2):78-84.
[10] Pijls LT, de Vries H, Donker AJ, et al. The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: a randomized trial[J]. Nephrol Dial Transplant,1999,14(6):1445-1453.
[11] Hansen HP, Tauber-Lassen E, Jensen BR, et al.Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy[J]. Kidney Int,2002,62(1):220-228.
[12] Klahr S, Levey AS, Beck GJ, et al.The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group[J]. N Engl J Med,1994,330(13):877-884.
[13] Levey AS, Greene T, Sarnak MJ, et al.Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study[J]. Am J Kidney Dis,2006,48(6):879-888.
[14] Dunkler D, Dehghan M, Teo KK, et al.Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus[J]. JAMA Intern Med,2013,173(18):1682-1692.
[15] Dunkler D, Kohl M, Teo KK, et al. Dietary risk factors for incidence or progression of chronic kidney disease in individuals with type 2 diabetes in the European Union[J]. Nephrol Dial Transplant,2015,30 (Suppl 4):iv76-iv85.
[16] Salem MA, AboElAsrar MA, Elbarbary NS, et al. Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial[J]. Diabetol Metab Syndr,2010,2(1):47.
[17] Tanasescu M, Leitzmann MF, Rimm EB, et al.Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes[J]. Circulation,2003,107(19):2435-2439.
[18] Tufescu A, Kanazawa M, Ishida A, et al.Combination of exercise and losartan enhances renoprotective and peripheral effects in spontaneously type 2 diabetes mellitus rats with nephropathy[J]. J Hypertens,2008,26(2):312-321.
[19] Somineni HK, Boivin GP, Elased KM.Daily exercise training protects against albuminuria and angiotensin converting enzyme 2 shedding in db/db diabetic mice[J]. J Endocrinol,2014,221(2):235-251.
[20] Kohzuki M, Kamimoto M, Wu XM, et al.Renal protective effects of chronic exercise and antihypertensive the-rapy in hypertensive rats with chronic renal failure[J]. J Hypertens,2001,19(10):1877-1882.
[21] Ishikawa Y, Gohda T, Tanimoto M, et al.Effect of exercise on kidney function, oxidative stress, and inflammation in type 2 diabetic KK-A(y) mice[J]. Exp Diabetes Res,2012,2012:702948.
[22] Zinman B, Ruderman N, Campaigne BN, et al.Physical activity/exercise and diabetes mellitus[J]. Diabetes Care,2003,26(Suppl 1):S73-S77.
[23] Lin HC, Peng CH, Chiou JY, et al.Physical activity is associated with decreased incidence of chronic kidney disease in type 2 diabetes patients: a retrospective cohort study in Taiwan[J]. Prim Care Diabetes,2014,8(4):315-321.
[24] Wadén J, Tikkanen HK, Forsblom C, et al.Leisure-time physical activity and development and progression of dia-betic nephropathy in type 1 diabetes: the FinnDiane Study[J]. Diabetologia,2015,58(5):929-936.
[25] Dunkler D, Kohl M, Heinze G, et al.Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus[J]. Kidney Int,2015,87(4):784-791.
[26] Cameron AJ, Magliano DJ, Söderberg S.A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality[J]. Obes Rev,2013,14(1):86-94.
[27] Thorn LM, Forsblom C, Fagerudd J, et al.Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study)[J]. Diabetes Care,2005,28(8):2019-2024.
[28] de Boer IH, Sibley SD, Kestenbaum B, et al. Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study[J]. J Am Soc Nephrol,2007,18(1):235-243.
[29] Huang WH, Chen CY, Lin JL, et al. High body mass index reduces glomerular filtration rate decline in type Ⅱ diabetes mellitus patients with stage 3 or 4 chronic kidney disease[J]. Medicine (Baltimore),2014 Aug,93(7):e41.
[30] Friedman AN, Chambers M, Kamendulis LM, et al.Short-term changes after a weight reduction intervention in advanced diabetic nephropathy[J]. Clin J Am Soc Nephrol,2013,8(11):1892-1898.
[31] Nicholson AS, Sklar M, Barnard ND, et al.Toward improved management of NIDDM: A randomized, controlled, pilot intervention using a lowfat, vegetarian diet[J]. Prev Med,1999,29(2):87-91.
[32] Stenlöf K, Rössner S, Vercruysse F, et al.Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes[J]. Diabetes Obes Metab,2007,9(3):360-368.
[33] Parving HH, Lewis JB, Ravid M, et al.Prevalence and risk factors for microalbuminuria in a referred cohort of type Ⅱ diabetic patients: a global perspective[J]. Kidney Int,2006,69(11):2057-2063.
[34] Chase HP, Garg SK, Marshall G, et al.Cigarette smoking increases the risk of albuminuria among subjects with type Ⅰ diabetes[J]. JAMA,1991,265(5):614-617.
[35] Feodoroff M, Harjutsalo V, Forsblom C, et al.Smoking and progression of diabetic nephropathy in patients with type 1 diabetes[J]. Acta Diabetol,2016,53(4):525-533.
[36] Phisitkul K, Hegazy K, Chuahirun T, et al.Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy[J]. Am J Med Sci,2008,335(4):284-291.
